New York, New York--(Newsfile Corp. - February 2, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Aquestive Therapeutics, Inc. ("Aquestive Therapeutics, Inc.") (NASDAQ: AQST) concerning potential violations of the federal securities laws.What Happened?On January 9, 2026, Aquestive announced it received a letter from the FDA, identifying deficiencies in its NDA application that preclude labeling discussions and post-market commitments for Anaphylm, for the emergency t ...

Core Viewpoint - First Western Financial, Inc. is under investigation for potential violations of federal securities laws following a disappointing earnings report that missed analyst expectations, leading to a significant drop in stock price [1][2]. Financial Performance - First Western reported fourth-quarter earnings of $0.34 per share for 2025, which was below analyst expectations [1]. - The company's stock price fell over 8% on January 23, 2026, in response to the earnings miss [2]. Legal Investigation - Levi & Korsinsky has initiated an investigation into First Western Financial regarding potential securities law violations [1]. - Investors who suffered losses are encouraged to explore recovery options under federal securities laws [2]. Firm Background - Levi & Korsinsky LLP has a strong reputation in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years [3]. - The firm has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [3].

Core Viewpoint - REGENXBIO Inc. is under investigation for potential violations of federal securities laws following the FDA's clinical holds on its RGX-111 and RGX-121 programs, which resulted in a significant decline in the company's share price by 30-35% [1]. Regulatory Compliance - Public companies are required to disclose material information to investors as per SEC disclosure rules, specifically through Form 8-K, which allows for the reporting of material events not covered by other items [2]. - Rule 10b-5 under the Securities Exchange Act of 1934 prohibits both material misstatements and omissions in securities transactions, emphasizing the need for complete and accurate disclosures [2]. Company Communication - During the Q3 2025 earnings call, CEO Curran Simpson highlighted positive regulatory interactions, noting that the FDA completed inspections with no observations, which may have created an asymmetric view of the company's regulatory status by not disclosing safety concerns being evaluated [3]. - The Q3 2025 earnings call transcript notably lacked any discussion regarding the RGX-111 program for MPS I, despite it being a significant pipeline asset that later faced the same FDA clinical hold, raising concerns about the completeness of information provided to shareholders [4].

Core Viewpoint - Bgin Blockchain Limited is under investigation for potential violations of federal securities laws following significant financial losses and changes in auditor engagement [1][2][3]. Financial Performance - Bgin Blockchain Limited reported a decline in total revenue of approximately $96 million for the six months ending June 30, 2025, compared to the previous year [2]. - The company's operating expenses surged by 582.8%, leading to a gross loss of $6.3 million, a stark contrast to the gross profit of $84.8 million reported in the prior year [2]. Auditor Engagement - On December 15, 2025, Bgin announced it would not renew its current auditor and instead approved the engagement of a new independent registered public accounting firm, effective December 12, 2025 [3]. - Following the announcement regarding the auditor change, Bgin's shares experienced a significant drop of over 59% on December 29, 2025 [3].

Core Viewpoint - There is a growing trend of comparing Advanced Micro Devices (AMD) and Nvidia Corp. (NVDA), which raises questions about the validity of such comparisons given the distinct differences between the two companies [1]. Group 1 - AMD and Nvidia are often compared, but the rationale behind these comparisons is unclear [1]. - The author emphasizes the need for a deeper understanding of each company's unique market position and business model [1].

Worried about an artificial intelligence (AI) bubble? CrowdStrike can allow you to hedge your portfolio while still allowing you to profit from AI's changes to the cybersecurity industry.Artificial intelligence (AI) is everywhere, and generative AI has been likely the biggest stock market story since ChatGPT debuted in 2022. Despite fears of a bubble forming, the market seems as bullish as ever on AI going into 2026.But if you want to hedge your bets on AI, the way to do it is by investing in companies that ...

Core Viewpoint - Apollo Silver Corp. has been accepted into the U.S. Defense Industrial Base Consortium (DIBC), which aims to enhance collaboration across industry, academia, and government to support U.S. defense and national security priorities [1][4]. Group 1: DIBC Membership - The DIBC focuses on strategic and critical materials essential to U.S. national security, including initiatives to improve the resilience and security of domestic critical mineral supply chains [2]. - As a member of the DIBC, Apollo Silver will engage in federally sponsored initiatives related to the mining and processing of critical minerals such as silver, zinc, and barite [4]. - The acceptance into the DIBC highlights the strategic importance of U.S.-based critical mineral assets, particularly silver, which was included in the USGS List of Critical Minerals in November 2025 [5]. Group 2: Company Projects - Apollo Silver's Calico Project hosts significant silver mineralization along with barite and zinc, which are classified as critical minerals and are vital for industrial, infrastructure, and defense applications [3]. - The company is advancing the second largest undeveloped primary silver project in the U.S., with the Calico Project recognized for its large, bulk minable silver deposit and significant barite and zinc credits [6]. - Apollo Silver also holds an option on the Cinco de Mayo Project in Chihuahua, Mexico, which features a major high-grade carbonate replacement deposit [6]. Group 3: Leadership and Strategy - The company is led by an experienced management team, positioning it to advance its assets and deliver value through exploration and development [6]. - The CEO of Apollo Silver emphasized the company's alignment with U.S. priorities focused on supply-chain security, industrial resilience, and national defense [5].

Group 1 - FUJIFILM Dimatix has launched the DMP-2850 S materials printer, an upgraded version of the DMP-2850, designed for researchers and universities, featuring improved hardware and software capabilities [1] - The DMP-2850 S supports micro-precision jetting for various functional fluids on multiple surfaces, including plastics, glass, ceramics, and flexible substrates [1] - Key enhancements include drop analysis for optimizing print head settings, a new print job feature for batching multiple jobs, and support for various file types such as BMP, JPEG, TIF, and PNG [1] Group 2 - The DMP-2850 S is equipped with FUJIFILM Dimatix's Samba-based print cartridge, utilizing Silicon MEMS processing for high-quality printing [1] - The integrated computer runs on Microsoft Windows 10 IoT Enterprise LTSC and features a more powerful CPU and dual USB ports for data transfer [1] - The printer is now available for shipping to customers, indicating a readiness for market deployment [1]

Group 1 - The article does not provide any relevant content regarding company or industry insights [1]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased common stock of Integer Holdings Corporation during the specified Class Period of the upcoming lead plaintiff deadline on February 9, 2026 [1] Group 1: Class Action Details - Investors who bought Integer common stock between July 25, 2024, and October 22, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2] - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by February 9, 2026 [3] - The Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [4] Group 2: Case Allegations - The lawsuit alleges that Integer Holdings Corporation made materially false and misleading statements regarding its competitive position in the electrophysiology manufacturing market [5] - It is claimed that Integer overstated its visibility into customer demand while experiencing a decline in sales for two of its electrophysiology devices [5] - The lawsuit asserts that Integer mischaracterized its electrophysiology devices as long-term growth drivers for its cardio and vascular segment, leading to misleading positive statements about its business and operations [5]